Related Experiment Video
Updated: Jan 30, 2026
04:34
Meta-Analysis of the Effectiveness and Safety of Shugan Jieyu Capsules for the Treatment of Insomnia
Published on: February 17, 2023
1.6K
Effectiveness of long-term using statins in COPD - a network meta-analysis.
Yongbin Lu1, Ruixia Chang2, Jia Yao1
1The First Hospital of Lanzhou University, Lanzhou, Gansu, People's Republic of China.
Respiratory Research
|January 25, 2019
Summary
Statins significantly reduce mortality risk and improve inflammatory markers like C-reactive protein (CRP) and pulmonary hypertension (PH) in patients with chronic obstructive pulmonary disease (COPD). Fluvastatin and Atorvastatin show superior efficacy in reducing CRP and PH.
Area of Science:
- Pulmonary Medicine
- Pharmacology
- Cardiovascular Research
Background:
- Chronic obstructive pulmonary disease (COPD) is a leading cause of morbidity and mortality worldwide.
- Inflammatory processes and cardiovascular complications significantly impact COPD progression and patient outcomes.
- Statins, primarily used for cardiovascular disease prevention, are being investigated for their potential benefits in COPD management.
Purpose of the Study:
- To evaluate the long-term effectiveness of statin therapy in patients with COPD.
- To compare the efficacy of different statin medications in managing COPD-related parameters.
- To assess the impact of statins on mortality, inflammatory markers, and lung function in COPD.
Main Methods:
- A comprehensive meta-analysis of studies from PubMed, Web of Science, Embase, and China National Knowledge Infrastructure was conducted.
- Pooled estimates for mortality, inflammatory factors (C-reactive protein), and pulmonary hypertension were calculated.
- A network meta-analysis was employed to directly compare the effectiveness of various statins in COPD patients.
Main Results:
- Statins demonstrated a significant reduction in all-cause mortality (RR 0.72), heart disease-related mortality (RR 0.72), and COPD acute exacerbations (RR 0.84).
- Statin use was associated with decreased levels of C-reactive protein (SMD -0.62) and pulmonary hypertension (SMD -0.71).
- Fluvastatin, Atorvastatin, and Rosuvastatin showed higher probabilities of reducing CRP, while Fluvastatin and Atorvastatin were most effective for reducing PH.
Conclusions:
- Long-term statin treatment is beneficial for COPD patients, reducing mortality risk and key inflammatory markers.
- Fluvastatin and Atorvastatin emerge as particularly effective statins for mitigating C-reactive protein levels and pulmonary hypertension in COPD.
- These findings support the consideration of statin therapy as an adjunct treatment strategy in managing COPD.
More Related Videos
Related Concept Videos
01:20COPD: Pathogenesis and Clinical Features
1.8K
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
1.8K
01:26COPD: Management Using Bronchodilators and Corticosteroids
811
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
811
02:26Protein Networks
4.5K
An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
4.5K
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
1.4K
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.4K
01:09Directing Effect of Substituents: meta-Directing Groups
6.0K
Substituents on the benzene ring that direct an incoming electrophile to undergo substitution at the meta position are called meta directors. All meta directors either have a positive charge on the atom directly bonded to the ring or a partial positive charge. These groups function by withdrawing electrons from the ring through inductive and resonance effects. Consider the carbocation intermediates formed upon the addition of an electrophile on nitrobenzene at the...
6.0K
02:18Network Covalent Solids
16.2K
Network covalent solids contain a three-dimensional network of covalently bonded atoms as found in the crystal structures of nonmetals like diamond, graphite, silicon, and some covalent compounds, such as silicon dioxide (sand) and silicon carbide (carborundum, the abrasive on sandpaper). Many minerals have networks of covalent bonds.
To break or to melt a covalent network solid, covalent bonds must be broken. Because covalent bonds are relatively strong, covalent network solids are typically...
To break or to melt a covalent network solid, covalent bonds must be broken. Because covalent bonds are relatively strong, covalent network solids are typically...
16.2K